Intelligent Bio Solutions Inc. (INBS)

Intelligent Bio Solutions Income Statement

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Operating Revenue	3.29	3.05	3.11	1.26	-	-
Other Revenue	-	-	-	-	-	1.98
Revenue	3.29	3.05	3.11	1.26	-	1.98
Revenue Growth (YoY)	3.26%	-1.90%	147.58%	-	-	949.30%
Cost of Revenue	1.87	1.81	1.69	0.93	-	-
Gross Profit	1.42	1.25	1.43	0.33	-	1.98
Selling, General & Admin	9.59	8.88	9.26	8.03	4.92	3.36
Research & Development	1.93	2.4	1.67	0.51	3.85	3.84
Other Operating Expenses	-0.88	-0.82	-0.42	-0.74	-0.44	-
Operating Expenses	11.86	11.67	11.71	8.76	8.34	7.19
Operating Income	-10.44	-10.42	-10.28	-8.44	-8.34	-5.21
Interest Expense	-0.04	-0.06	-0.17	-0.22	-0.01	-1.09
Interest & Investment Income	0.06	0.1	0.08	0.01	0.01	0.01
Earnings From Equity Investments	-	-	-	-	-	-0.14
Currency Exchange Gain (Loss)	-0	-0	-0	-0.01	-0	-0.27
Other Non Operating Income (Expenses)	-	-	0.18	2.15	-	-0.36
EBT Excluding Unusual Items	-10.42	-10.38	-10.19	-6.51	-8.33	-7.06
Impairment of Goodwill	-	-	-	-4.16	-	-
Asset Writedown	-0.48	-0.22	-	-	-	-
Pretax Income	-10.91	-10.6	-10.19	-10.66	-8.33	-7.06
Earnings From Continuing Operations	-10.91	-10.6	-10.19	-10.66	-8.33	-7.06
Minority Interest in Earnings	0.04	0.04	0.03	0.03	0.03	0.02
Net Income	-10.87	-10.57	-10.16	-10.63	-8.31	-7.04
Net Income to Common	-10.87	-10.57	-10.16	-10.63	-8.31	-7.04
Shares Outstanding (Basic)	6	5	2	0	0	0
Shares Outstanding (Diluted)	6	5	2	0	0	0
Shares Change (YoY)	158.62%	231.10%	1802.54%	37.00%	40.81%	22.38%
EPS (Basic)	-1.68	-2.00	-6.38	-127.00	-135.93	-162.17
EPS (Diluted)	-1.68	-2.00	-6.38	-127.00	-135.93	-162.17
Free Cash Flow	-10.44	-9.91	-9.79	-7.88	-3.74	-11.3
Free Cash Flow Per Share	-1.62	-1.88	-6.15	-94.16	-61.18	-260.32
Gross Margin	43.08%	40.85%	45.81%	25.99%	-	100.00%
Operating Margin	-317.04%	-341.50%	-330.46%	-671.24%	-	-263.28%
Profit Margin	-330.07%	-346.23%	-326.40%	-845.89%	-	-355.33%
Free Cash Flow Margin	-317.10%	-324.62%	-314.71%	-627.15%	-	-570.39%
EBITDA	-9.45	-9.45	-9.31	-7.62	-	-
EBITDA Margin	-287.08%	-	-299.15%	-	-	-
D&A For EBITDA	0.99	0.97	0.97	0.81	-	-
EBIT	-10.44	-10.42	-10.28	-8.44	-8.34	-5.21
EBIT Margin	-	-	-	-	-	-263.28%
Revenue as Reported	-	-	-	-	-	1.98
Advertising Expenses	-	1.55	0.73	-	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q